Queensland Centre for Gynaecological Cancer
Quick facts
Marketed products
- Paclitaxel, Carboplatin · Oncology
Paclitaxel and carboplatin work together as a chemotherapy combination that stabilizes microtubules and causes DNA damage to kill cancer cells.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- Queensland Centre for Gynaecological Cancer portfolio CI brief
- Queensland Centre for Gynaecological Cancer pipeline updates RSS
Frequently asked questions about Queensland Centre for Gynaecological Cancer
What are Queensland Centre for Gynaecological Cancer's marketed drugs?
Top marketed products include Paclitaxel, Carboplatin.
Related
- Paclitaxel, Carboplatin · Oncology
- Sector hub: All tracked pharma companies